Source:http://linkedlifedata.com/resource/pubmed/id/17621405
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2007-7-10
|
| pubmed:abstractText |
Vascular endothelial growth factor (VEGF) has been described as an essential cytokine in the regulation of angiogenesis. Its elevation in peripheral blood or bone marrow has been associated with an unfavorable outcome in different hematologic neoplasms. Hodgkin lymphoma represents approximately one fifth of all lymphomas, and the roles of angiogenesis and VEGF in Hodgkin lymphoma have not been well defined at present.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1557-9190
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
400-5
|
| pubmed:meshHeading |
pubmed-meshheading:17621405-Disease Progression,
pubmed-meshheading:17621405-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17621405-Female,
pubmed-meshheading:17621405-Hodgkin Disease,
pubmed-meshheading:17621405-Humans,
pubmed-meshheading:17621405-Male,
pubmed-meshheading:17621405-Neovascularization, Pathologic,
pubmed-meshheading:17621405-Statistics, Nonparametric,
pubmed-meshheading:17621405-Tumor Burden,
pubmed-meshheading:17621405-Vascular Endothelial Growth Factor A
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Elevated vascular endothelial growth factor pretreatment levels are correlated with the tumor burden in Hodgkin lymphoma and continue to be elevated in prolonged complete remission.
|
| pubmed:affiliation |
Oncology Department, Hospital Clinico Universitario, Malaga, Spain.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|